Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-043288

Options or other derivatives

  • EVP, Drug Development acquired 165,961 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
MANHARD KIMBERLY EVP, Drug Development 2022-07-25 Grant or award · Employee Stock Option (Right to Buy) +165,961 165,961 D: show line 1 in the form
Loading xslF345X03/doc4.xml…